Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Curi Bio logo — Human Data for Next Generation Medicines

Curi Bio

Human Data for Next Generation Medicines

Founded 2015 United States Seattle, United States 59 employees Grant Total: $20.40M AI, Biopharma +1

General Information

Company Name Curi Bio
Founded Year 2015
Location United States Seattle, United States +1
Employees 59
Industries AI, Biopharma, Biotechnology
Funding Stage Grant
Social

Get notified when Curi Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Curi Bio

Curi Bio is a biopharma and biotechnology startup founded in 2015 with the slogan "Human Data for Next Generation Medicines." The company focuses on unlocking novel workflows and critical human data to inform R&D decision-making. Through an integrated platform, which includes advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/ML-enabled insights, Curi Bio merges functional and analytical assessments for drug safety, efficacy, and potency. Notably, Curi Bio recently secured a $4.40M grant investment on 23 August 2023 from the National Institutes of Health. This investment signifies external validation and support for Curi Bio's innovative approach and technologies. As the company continues to expand its capabilities and leverage human data for the development of next-generation medicines, it remains positioned to make a significant impact in the biopharma and biotechnology industries.

Taxonomy: 3D tissue models, biosystems, AI/ML-enabled insights, drug safety, efficacy, potency, tissue engineering, stem cell biology, mechanobiology, drug screening, drug development, high-throughput screening, iPSC-CM, disease modeling

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 23 Aug 2023
Series A •••••• 3
Investor Investor Investor
29 Dec 2021
Series A •••••• 1
Investor
18 Mar 2021

Curi Bio Alternatives & Competitors

Curi Bio vs
Celogics
Celogics United States

Quality Cells, Quality Research. Providing iPSC differentiation services for pharmaceutical research

3 employees
Biotechnology, Manufacturing
Compare Curi Bio vs Celogics
Curi Bio vs
Cyfuse Biomedical K.K.
Cyfuse Biomedical K.K.

Cyfuse contribute to significant advances in medical treatments and drug discovery through its revol...

Series Unknown
2 employees
Biotechnology, Health Care
Compare Curi Bio vs Cyfuse Biomedical K.K.
Curi Bio vs
Kadimastem Ltd.
Kadimastem Ltd. Israel

A clinical stage biotech company using PLATFORM TECH for the Manufacturing of cells for ALS and Diab...

Grant
32 employees
Biotechnology, Health and Wellness
Compare Curi Bio vs Kadimastem Ltd.
Also compare with: Curi Bio vs Prellis Biologics Prellis Biologics

FAQ About Curi Bio

Human Data for Next Generation Medicines
Curi Bio was founded in 2015.
Curi Bio is headquartered in Seattle, United States.
Curi Bio operates in the following industries: AI, Biopharma, Biotechnology.
Curi Bio has approximately 59 employees.
Curi Bio has completed 3 funding rounds, raising a total of $20.40M. The latest funding stage is Grant.
Top alternatives and competitors to Curi Bio include Celogics, Cyfuse Biomedical K.K., Kadimastem Ltd., Precise Bio, Axolotl Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Curi Bio and Celogics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Curi Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy